Clinical Edge Journal Scan

Exposure to volatile organic compounds raises risk for RA


 

Key clinical point: Exposure to volatile organic compounds (VOC) significantly increased the risk for rheumatoid arthritis (RA), highlighting environmental pollutants as a risk factor for RA.

Major finding: Patients with RA had a significantly higher urine concentration of seven VOC than those without arthritis (all P < .05). The risk for RA was significantly higher among those in the highest vs lowest concentration quantile of AMCC (adjusted odds ratio [aOR] 2.173; 95% CI 1.021-4.627) and 3HPMA (aOR 2.663; 95% CI 1.288-5.508), with the parent compounds being N,N-Dimethylformamide and acrolein, respectively.

Study details: This cross-sectional study included 9536 participants with complete information on 15 urine VOC, of whom 618 participants had RA and 8918 did not have arthritis.

Disclosures: This study was supported by the Fundamental Research Funds for the Central Universities of Central South University, the National Natural Science Foundation of China, and other sources. The authors declared no conflicts of interest.

Source: Lei T et al. The exposure to volatile organic chemicals associates positively with rheumatoid arthritis: A cross-sectional study from the NHANES program. Front Immunol. 2023;14:1098683 (Jun 19). Doi: 10.3389/fimmu.2023.1098683

Recommended Reading

Methotrexate does not impair sperm quality, small study finds
MDedge Rheumatology
Commentary: DMARD and HCQ in RA, July 2023
MDedge Rheumatology
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
MDedge Rheumatology
Antidrug antibody effects compared across RA biologics
MDedge Rheumatology
Humira biosimilars: Five things to know
MDedge Rheumatology
Tofacitinib shows marginal edge over adalimumab in real-world patients with RA
MDedge Rheumatology
Certolizumab pegol and abatacept show superiority over conventional therapy in early RA
MDedge Rheumatology
Joint involvement starts earlier and more severely in hands than in feet in RA
MDedge Rheumatology
Joint tenderness at 3 months post-diagnosis predicts long-term pain in early RA
MDedge Rheumatology
Small and favorable changes in body composition with low-dose prednisolone in elderly patients with active RA
MDedge Rheumatology